AVX101

· AlphaVax, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AVX101, covering 2012-07-02 to 2012-07-02. Get the full timeline:

Most recent: Clinical Trial Update: Safety of and Immune Response to an HIV-1 Subtype C Vaccine (AVX101) in HIV Uninfected Adults [Phase 1]